Summary

In Italy respiratory diseases, after cardiovascular and malignant diseases, are the 3rd leading cause of death and, given the aging population, their prevalence is expected to rise in the next decades. The fight against respiratory diseases is primarily on two fronts: primary prevention (e.g. through interventions against smoking and pollutants in the home and workplace) and secondary prevention (e.g. early diagnosis). In Italy, The Italian Ministry of Health (MoH) has made respiratory disease prevention a top priority and is implementing a comprehensive strategy with policies against tobacco smoking, indoor/outdoor pollution, obesity, and communicable diseases. As per the International Respiratory Coalition; Italy had the highest number of cases of COPD, with 3.3 Million people suffered from it and has the death toll of 28,080. Along with this, the number of Asthma cases in Italy was 2.6 Million with 537 deaths. This increasing prevalence of these disorders is driven by a complex interplay of factors that are reshaping the healthcare landscape in the country. Firstly, environmental factors are playing a pivotal role, with air pollution, including fine particulate matter and industrial emissions, being a substantial contributor to respiratory issues. Long-term exposure to these pollutants has been linked to the development and exacerbation of conditions such as chronic obstructive pulmonary disease (COPD) and asthma. France's aging population is another significant factor contributing to the increasing burden of respiratory disorders. Respiratory conditions tend to be more prevalent among older individuals, and as the population ages, the prevalence of disorders like COPD and sleep apnea continues to rise. Moreover, changing climate patterns and the prevalence of respiratory infections, such as pneumonia, have added complexity to the issue. The relationship between climate change, allergenic factors, and respiratory health is an emerging concern and one that is being closely monitored.

According to the research report "Italy Respiratory Care Devices Market Overview, 2028," published by Bonafide Research, the market is anticipated to add more than 35 Million from 2023 to 2028. In Italy, the manufacturing of respiratory care devices has been on the rise, contributing significantly to the overall expansion of the market. This growth is underpinned by several key factors that reflect Italy's commitment to producing high-quality, cutting-edge medical equipment. Italian companies have channeled substantial investments into research and developments, resulting in the introduction of advanced technologies that enhance patient care, improve treatment efficacy, and cater to the specific needs of individuals with respiratory conditions. One of the primary drivers behind this surge in manufacturing is Italy's strong tradition of engineering and innovation. The country has a rich history of excellence in healthcare technology, attracting talent and expertise from both domestic sources and international collaborations. This commitment to innovation extends to environmentally sustainable practices, with a focus on energy efficiency and reducing the environmental footprint of respiratory care devices. Consequently, Italian manufacturers are not only meeting the growing demand for respiratory care devices but also ensuring they are produced with environmental responsibility in mind. Italy's strategic location within Europe and its robust transportation and logistics infrastructure have allowed companies to efficiently distribute their products not only to domestic markets but also to international ones. This positioning, combined with Italy's adherence to stringent quality control measures, including ISO certifications and CE marking, guarantees that products manufactured in the country adhere to international regulatory requirements, ensuring both patient safety and product quality.

In Italy, the respiratory equipment market is systematically divided into four categories: therapeutic devices, monitoring devices, diagnostic devices, and consumables and accessories. Among these segments, therapeutic devices emerge as the dominant force, enjoying a significant market share. The prevalence of respiratory conditions like asthma and COPD in Italy underscores the demand for a wide array of therapeutic solutions, including inhalers, nebulizers, and oxygen therapy equipment. Monitoring and diagnostic devices also hold a substantial share as healthcare professionals rely on these tools for tracking patient progress and accurate diagnosis. Within the respiratory equipment market, the landscape of disease indications in the healthcare sector is both diverse and critical, encompassing a range of conditions that significantly influence the demand for respiratory devices. Chronic obstructive pulmonary disease (COPD) stands out as the market leader, commanding a substantial share. The prevalence of COPD, a chronic and progressive lung disease, necessitates a wide array of therapeutic, monitoring, and diagnostic devices, contributing to its significant presence in the market. Sleep apnea, characterized by interrupted breathing during sleep, has gained increasing recognition due to its potential health risks, driving the demand for specialized devices like continuous positive airway pressure (CPAP) machines and other respiratory equipment used to treat sleep-disordered breathing, ensuring patients receive effective therapy and improved sleep quality. Asthma, a widespread respiratory disorder, is also a vital contributor, with inhalers and nebulizers being integral components of asthma management. The Italy market for respiratory equipment encompasses a wide array of disease indications including chronic obstructive pulmonary disease (COPD), sleep apnea, asthma, infectious diseases, and other disease indications. COPD, a progressive and debilitating lung condition often caused by smoking or long-term exposure to irritants, necessitates a wide array of therapeutic, monitoring, and diagnostic devices, thereby commanding a substantial presence in the market. Patients with COPD rely on devices such as inhalers, nebulizers, and oxygen therapy solutions to alleviate their symptoms and improve their quality of life. The high prevalence of COPD, coupled with the increasing aging population, underscores the demand for these devices, making them an essential component of the respiratory equipment market.

In the realm of respiratory equipment, the market segmentation based on end-users is indicative of the dynamic and comprehensive nature of healthcare delivery systems. This segmentation encompasses a diverse range of institutions and facilities that collectively contribute to the provision of respiratory care. Notably, hospitals emerge as the predominant and major players in this market. These healthcare institutions, characterized by their extensive resources, specialized medical staff, and advanced infrastructure, serve as central hubs for respiratory healthcare. Hospitals are equipped with a wide array of respiratory devices, including ventilators, oxygen delivery systems, and advanced monitoring equipment, to provide immediate and intensive care to patients with acute and severe respiratory conditions. Their significant market share reflects their crucial role as the primary point of care for complex cases, setting the standard for excellence in respiratory care. Ambulatory Care Centers (ACCs) form another influential segment in the market. These outpatient facilities offer specialized respiratory care, diagnostics, and treatment services, catering to patients who require ongoing monitoring, diagnosis, and treatment but do not necessarily need the level of intervention provided by hospitals. ACCs are equipped with a range of monitoring and diagnostic devices, enabling efficient and effective care delivery and contributing significantly to the market's growth. Their role in providing accessible and timely care aligns with the evolving trends in healthcare, emphasizing the importance of preventive and outpatient services.

Considered in this report:
• Geography: Italy
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report:
• Italy Respiratory Care Devices market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product Type:
• Therapeutic Devices
• Monitoring Devices
• Diagnostic Devices
• Consumables and Accessories

By Disease Indication:
• Chronic Obstructive Pulmonary disease (COPD)
• Sleep Apnea
• Asthma
• Infectious Diseases
• Other Disease Indications

By End User:
• Hospitals
• Ambulatory Care Centers (ACCs)
• Home Care Settings
• Other End User

The approach of the report:
This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, and annual reports of companies, analyzing the government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers into regional aspects, tier aspects, age groups, and gender. Once we have primary data with us we started verifying the details obtained from secondary sources.

Intended audience:
This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the Respiratory Care Devices industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.

ページTOPに戻る

Table of Contents